Health Care : Current Reviews

Abstract

Would it be advantageous utilizing beta cell therapies over immunotherapies for avoidance of type 1 diabetes - A systematic Review on the role of beta cells in etiopathogenesis of type 1 diabetes along with treatments targeting beta cells or combination therapy would be better

Kulvinder Kochar Kaur

Earlier we had reviewed various aspects of Type 1 Diabetes (T1D) (its etiopathogenesis, various immunotherapies used and how we could try to obviate the need of insulin, role of empagliflozin addition, role of extracellular vesicles(ECV’s) in treating complications associated with T1D, role of gut microbiota and early life feeding, genes responsible (unpublished ),epigenetics in Diabetic Kidney Disease(DKD), The etiopathogenesis of T1D despite the earlier belief that it represents an autoimmune diseases with continuing autoimmune modulated damage of pancreatic β cells.

Published Date: 2021-07-14; Received Date: 2021-06-24